Wellcome

Wellcome is a UK-based independent charitable foundation that supports research to improve health by providing funding for pioneering projects and fostering collaborative research environments. The organization was founded in 1936 by Sir Henry Wellcome, a pharmaceutical entrepreneur, and focuses on science, innovation, and society. Wellcome's funding comes from the returns of its investment portfolio. They work with researchers worldwide to tackle pressing health challenges facing humanity.

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site is known for its high journalistic standards. It strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. It has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

  • Three Leading Foundations Join Forces to Invest $300M in Global Health Research and Development

    Three Leading Foundations Join Forces to Invest $300M in Global Health Research and Development

    Broke On: Monday, 06 May 2024 Three leading foundations - Novo Nordisk, Wellcome, and the Bill & Melinda Gates Foundation - have pledged $300 million over three years to tackle global health equity issues such as climate change impacts, infectious diseases including antimicrobial resistance (AMR), and disease surveillance. The partnership aims to open doors for further contributions from other funders and partners, with initial funding focusing on climate/sustainability, infectious diseases, and nutrition interactions.